LINEAGE INC (LINE) Fundamental Analysis & Valuation

NASDAQ:LINE • US53566V1061

36.84 USD
-0.03 (-0.08%)
Last: Mar 13, 2026, 11:51 AM
Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership News

This LINE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

3

LINE gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 123 industry peers in the Diversified REITs industry. LINE may be in some trouble as it scores bad on both profitability and health. LINE is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

2

1. LINE Profitability Analysis

1.1 Basic Checks

  • In the past year LINE has reported negative net income.
  • In the past year LINE had a positive cash flow from operations.
  • In the past 5 years LINE always reported negative net income.
  • LINE had a positive operating cash flow in each of the past 5 years.
LINE Yearly Net Income VS EBIT VS OCF VS FCFLINE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 2025 0 500M -500M

1.2 Ratios

  • LINE's Return On Assets of -0.51% is on the low side compared to the rest of the industry. LINE is outperformed by 63.41% of its industry peers.
  • With a Return On Equity value of -1.19%, LINE is not doing good in the industry: 64.23% of the companies in the same industry are doing better.
  • Looking at the Return On Invested Capital, with a value of 1.12%, LINE is doing worse than 78.86% of the companies in the same industry.
  • The Average Return On Invested Capital over the past 3 years for LINE is in line with the industry average of 3.11%.
Industry RankSector Rank
ROA -0.51%
ROE -1.19%
ROIC 1.12%
ROA(3y)-1.57%
ROA(5y)-1.21%
ROE(3y)-3.63%
ROE(5y)-3.18%
ROIC(3y)1.65%
ROIC(5y)1.58%
LINE Yearly ROA, ROE, ROICLINE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 2025 0 2 -2 -4 -6 -8

1.3 Margins

  • The Operating Margin of LINE (4.69%) is worse than 82.93% of its industry peers.
  • In the last couple of years the Operating Margin of LINE has declined.
  • The Gross Margin of LINE (32.14%) is worse than 86.99% of its industry peers.
  • LINE's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 4.69%
PM (TTM) N/A
GM 32.14%
OM growth 3Y-15.1%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.87%
GM growth 5YN/A
LINE Yearly Profit, Operating, Gross MarginsLINE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 2025 0 10 -10 20 30

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. LINE Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), LINE is destroying value.
  • LINE has less shares outstanding than it did 1 year ago.
  • Compared to 1 year ago, LINE has a worse debt to assets ratio.
LINE Yearly Shares OutstandingLINE Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 2025 50M 100M 150M 200M
LINE Yearly Total Debt VS Total AssetsLINE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 2025 5B 10B 15B

2.2 Solvency

  • Based on the Altman-Z score of 0.58, we must say that LINE is in the distress zone and has some risk of bankruptcy.
  • With a Altman-Z score value of 0.58, LINE perfoms like the industry average, outperforming 55.28% of the companies in the same industry.
  • The Debt to FCF ratio of LINE is 37.78, which is on the high side as it means it would take LINE, 37.78 years of fcf income to pay off all of its debts.
  • LINE's Debt to FCF ratio of 37.78 is fine compared to the rest of the industry. LINE outperforms 69.92% of its industry peers.
  • A Debt/Equity ratio of 0.89 indicates that LINE is somewhat dependend on debt financing.
  • Looking at the Debt to Equity ratio, with a value of 0.89, LINE is in the better half of the industry, outperforming 62.60% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.89
Debt/FCF 37.78
Altman-Z 0.58
ROIC/WACC0.18
WACC6.4%
LINE Yearly LT Debt VS Equity VS FCFLINE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 2025 0 2B 4B 6B 8B 10B

2.3 Liquidity

  • A Current Ratio of 0.80 indicates that LINE may have some problems paying its short term obligations.
  • LINE has a Current ratio (0.80) which is comparable to the rest of the industry.
  • LINE has a Quick Ratio of 0.80. This is a bad value and indicates that LINE is not financially healthy enough and could expect problems in meeting its short term obligations.
  • With a Quick ratio value of 0.71, LINE is not doing good in the industry: 60.16% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.8
Quick Ratio 0.71
LINE Yearly Current Assets VS Current LiabilitesLINE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 2025 500M 1B 1.5B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. LINE Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 86.24% over the past year.
  • The Revenue has been growing slightly by 0.28% in the past year.
  • Measured over the past years, LINE shows a small growth in Revenue. The Revenue has been growing by 2.81% on average per year.
EPS 1Y (TTM)86.24%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%127.27%
Revenue 1Y (TTM)0.28%
Revenue growth 3Y2.81%
Revenue growth 5YN/A
Sales Q2Q%-0.22%

3.2 Future

  • The Earnings Per Share is expected to grow by 17.20% on average over the next years. This is quite good.
  • Based on estimates for the next years, LINE will show a small growth in Revenue. The Revenue will grow by 6.75% on average per year.
EPS Next Y-69.3%
EPS Next 2Y-23.27%
EPS Next 3Y-14.49%
EPS Next 5Y17.2%
Revenue Next Year1.44%
Revenue Next 2Y2.34%
Revenue Next 3Y-4.84%
Revenue Next 5Y6.75%

3.3 Evolution

  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
LINE Yearly Revenue VS EstimatesLINE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2B 4B 6B
LINE Yearly EPS VS EstimatesLINE Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 2027 2028 2029 2030 0 -0.5 -1 -1.5 -2 -2.5

More info and screens

Find the best growth stocksShow best growing peers

2

4. LINE Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for LINE. In the last year negative earnings were reported.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for LINE. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
LINE Price Earnings VS Forward Price EarningsLINE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 50 -50

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, LINE is valued a bit cheaper than 61.79% of the companies in the same industry.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of LINE indicates a somewhat cheap valuation: LINE is cheaper than 71.54% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 42.68
EV/EBITDA 13.71
LINE Per share dataLINE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30

4.3 Compensation for Growth

  • LINE's earnings are expected to decrease with -14.49% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-23.27%
EPS Next 3Y-14.49%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

4

5. LINE Dividend Analysis

5.1 Amount

  • LINE has a Yearly Dividend Yield of 5.21%, which is a nice return.
  • Compared to an average industry Dividend Yield of 7.59, LINE has a dividend in line with its industry peers.
  • Compared to an average S&P500 Dividend Yield of 1.82, LINE pays a better dividend.
Industry RankSector Rank
Dividend Yield 5.21%

5.2 History

  • LINE has been paying a dividend for over 5 years, so it has already some track record.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
LINE Yearly Dividends per shareLINE Yearly Dividends per shareYearly Dividends per share 2024 2025 0.5 1 1.5 2

5.3 Sustainability

  • The earnings of LINE are negative and hence is the payout ratio. LINE will probably not be able to sustain this dividend level.
DP-491.84%
EPS Next 2Y-23.27%
EPS Next 3Y-14.49%
LINE Yearly Income VS Free CF VS DividendLINE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2021 2022 2023 2024 2025 0 200M -200M 400M -400M -600M

More info and screens

Find the best dividend stocksShow peers with best dividend

LINE Fundamentals: All Metrics, Ratios and Statistics

LINEAGE INC

NASDAQ:LINE (3/13/2026, 11:51:34 AM)

36.84

-0.03 (-0.08%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)02-25
Earnings (Next)04-28
Inst Owners33.94%
Inst Owner Change0.81%
Ins Owners0.22%
Ins Owner Change-0.74%
Market Cap8.37B
Revenue(TTM)5.36B
Net Income(TTM)-98.00M
Analysts67.2
Price Target40.4 (9.66%)
Short Float %13.52%
Short Ratio5.54
Dividend
Industry RankSector Rank
Dividend Yield 5.21%
Yearly Dividend2.12
Dividend Growth(5Y)N/A
DP-491.84%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-118.8%
Min EPS beat(2)-404.2%
Max EPS beat(2)166.59%
EPS beat(4)1
Avg EPS beat(4)-79.82%
Min EPS beat(4)-404.2%
Max EPS beat(4)166.59%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-3.52%
Min Revenue beat(2)-4.98%
Max Revenue beat(2)-2.06%
Revenue beat(4)0
Avg Revenue beat(4)-3.26%
Min Revenue beat(4)-5.42%
Max Revenue beat(4)-0.59%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0.56%
PT rev (3m)-8.47%
EPS NQ rev (1m)-125%
EPS NQ rev (3m)-305%
EPS NY rev (1m)-52.8%
EPS NY rev (3m)-157.86%
Revenue NQ rev (1m)-0.59%
Revenue NQ rev (3m)-2.1%
Revenue NY rev (1m)-0.39%
Revenue NY rev (3m)-2.11%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.56
P/FCF 42.68
P/OCF 8.87
P/B 1.01
P/tB 2.27
EV/EBITDA 13.71
EPS(TTM)-0.44
EYN/A
EPS(NY)-0.74
Fwd EYN/A
FCF(TTM)0.86
FCFY2.34%
OCF(TTM)4.15
OCFY11.27%
SpS23.58
BVpS36.31
TBVpS16.25
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -0.51%
ROE -1.19%
ROCE 1.42%
ROIC 1.12%
ROICexc 1.13%
ROICexgc 1.52%
OM 4.69%
PM (TTM) N/A
GM 32.14%
FCFM 3.66%
ROA(3y)-1.57%
ROA(5y)-1.21%
ROE(3y)-3.63%
ROE(5y)-3.18%
ROIC(3y)1.65%
ROIC(5y)1.58%
ROICexc(3y)1.66%
ROICexc(5y)1.59%
ROICexgc(3y)2.25%
ROICexgc(5y)2.17%
ROCE(3y)2.08%
ROCE(5y)2%
ROICexgc growth 3Y-13.82%
ROICexgc growth 5YN/A
ROICexc growth 3Y-13.4%
ROICexc growth 5YN/A
OM growth 3Y-15.1%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.87%
GM growth 5YN/A
F-Score4
Asset Turnover0.28
Health
Industry RankSector Rank
Debt/Equity 0.89
Debt/FCF 37.78
Debt/EBITDA 6.39
Cap/Depr 83.46%
Cap/Sales 13.95%
Interest Coverage 0.84
Cash Conversion 82.29%
Profit Quality N/A
Current Ratio 0.8
Quick Ratio 0.71
Altman-Z 0.58
F-Score4
WACC6.4%
ROIC/WACC0.18
Cap/Depr(3y)87.72%
Cap/Depr(5y)99.47%
Cap/Sales(3y)13.74%
Cap/Sales(5y)15.27%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)86.24%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%127.27%
EPS Next Y-69.3%
EPS Next 2Y-23.27%
EPS Next 3Y-14.49%
EPS Next 5Y17.2%
Revenue 1Y (TTM)0.28%
Revenue growth 3Y2.81%
Revenue growth 5YN/A
Sales Q2Q%-0.22%
Revenue Next Year1.44%
Revenue Next 2Y2.34%
Revenue Next 3Y-4.84%
Revenue Next 5Y6.75%
EBIT growth 1Y-27.67%
EBIT growth 3Y-12.72%
EBIT growth 5YN/A
EBIT Next Year399.35%
EBIT Next 3Y78.96%
EBIT Next 5Y54.67%
FCF growth 1Y1533.33%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y34.14%
OCF growth 3Y23.48%
OCF growth 5YN/A

LINEAGE INC / LINE FAQ

What is the fundamental rating for LINE stock?

ChartMill assigns a fundamental rating of 3 / 10 to LINE.


What is the valuation status for LINE stock?

ChartMill assigns a valuation rating of 2 / 10 to LINEAGE INC (LINE). This can be considered as Overvalued.


How profitable is LINEAGE INC (LINE) stock?

LINEAGE INC (LINE) has a profitability rating of 2 / 10.


How financially healthy is LINEAGE INC?

The financial health rating of LINEAGE INC (LINE) is 3 / 10.


How sustainable is the dividend of LINEAGE INC (LINE) stock?

The dividend rating of LINEAGE INC (LINE) is 4 / 10 and the dividend payout ratio is -491.84%.